Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joshua W Russo

Showing results (11-20 of 26) with videos related to

Pageof 3
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 26, 2017
Gleason Score 7 Prostate Cancers Emerge through Branched Evolution of Clonal Gleason Pattern 3 and 4Adam G Sowalsky, Haydn T Kissick, Sean J Gerrin, et al.
Clinical Proteomics|July 12, 2026
Targeted proteomics for the detection of androgen receptor variants in preclinical models of castration-resistant prostate cancerZoi E Sychev, Gabrianne Larson, Megan L Ludwig, et al.
Cancer Research|September 23, 2018
Downregulation of <i>Dipeptidyl Peptidase 4</i> Accelerates Progression to Castration-Resistant Prostate CancerJoshua W Russo, Ce Gao, Swati S Bhasin, et al.
Nature Communications|December 16, 2021
Androgen receptor and MYC equilibration centralizes on developmental super-enhancerHaiyang Guo, Yiming Wu, Mannan Nouri, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 12, 2025
Increased ErbB2 signaling is an early adaptation to androgen signaling inhibition and persists in castration resistant prostate cancerJude Owiredu, Betul Ersoy-Fazlioglu, Larysa Poluben, et al.
Cancer Research|February 8, 2022
Autocrine Canonical Wnt Signaling Primes Noncanonical Signaling through ROR1 in Metastatic Castration-Resistant Prostate CancerFen Ma, Seiji Arai, Keshan Wang, et al.
Biorxiv : the Preprint Server for Biology|January 23, 2024
Increased chromatin accessibility mediated by nuclear factor I drives transition to androgen receptor splice variant dependence in castration-resistant prostate cancerLarysa Poluben, Mannan Nouri, Jiaqian Liang, et al.
The Journal of Clinical Investigation|December 1, 2025
Androgen deprivation-mediated activation of AKT is enhanced in prostate cancer with TMPRSS2:ERG fusionFen Ma, Sen Chen, Luigi Cecchi, et al.
Cancer Research|June 21, 2018
Neoadjuvant-Intensive Androgen Deprivation Therapy Selects for Prostate Tumor Foci with Diverse Subclonal Oncogenic AlterationsAdam G Sowalsky, Huihui Ye, Manoj Bhasin, et al.
Cell Reports|December 22, 2024
Increased nuclear factor I-mediated chromatin access drives transition to androgen receptor splice variant dependence in prostate cancerLarysa Poluben, Mannan Nouri, Jiaqian Liang, et al.
Pageof 3

Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 26, 2017
Gleason Score 7 Prostate Cancers Emerge through Branched Evolution of Clonal Gleason Pattern 3 and 4Adam G Sowalsky, Haydn T Kissick, Sean J Gerrin, et al.
Clinical Proteomics|July 12, 2026
Targeted proteomics for the detection of androgen receptor variants in preclinical models of castration-resistant prostate cancerZoi E Sychev, Gabrianne Larson, Megan L Ludwig, et al.
Cancer Research|September 23, 2018
Downregulation of <i>Dipeptidyl Peptidase 4</i> Accelerates Progression to Castration-Resistant Prostate CancerJoshua W Russo, Ce Gao, Swati S Bhasin, et al.
Nature Communications|December 16, 2021
Androgen receptor and MYC equilibration centralizes on developmental super-enhancerHaiyang Guo, Yiming Wu, Mannan Nouri, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 12, 2025
Increased ErbB2 signaling is an early adaptation to androgen signaling inhibition and persists in castration resistant prostate cancerJude Owiredu, Betul Ersoy-Fazlioglu, Larysa Poluben, et al.
Cancer Research|February 8, 2022
Autocrine Canonical Wnt Signaling Primes Noncanonical Signaling through ROR1 in Metastatic Castration-Resistant Prostate CancerFen Ma, Seiji Arai, Keshan Wang, et al.
Biorxiv : the Preprint Server for Biology|January 23, 2024
Increased chromatin accessibility mediated by nuclear factor I drives transition to androgen receptor splice variant dependence in castration-resistant prostate cancerLarysa Poluben, Mannan Nouri, Jiaqian Liang, et al.
The Journal of Clinical Investigation|December 1, 2025
Androgen deprivation-mediated activation of AKT is enhanced in prostate cancer with TMPRSS2:ERG fusionFen Ma, Sen Chen, Luigi Cecchi, et al.
Cancer Research|June 21, 2018
Neoadjuvant-Intensive Androgen Deprivation Therapy Selects for Prostate Tumor Foci with Diverse Subclonal Oncogenic AlterationsAdam G Sowalsky, Huihui Ye, Manoj Bhasin, et al.
Cell Reports|December 22, 2024
Increased nuclear factor I-mediated chromatin access drives transition to androgen receptor splice variant dependence in prostate cancerLarysa Poluben, Mannan Nouri, Jiaqian Liang, et al.
Pageof 3